Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (111-120 of 435) with videos related to

Pageof 44
Sort By:
Journal of Clinical Epidemiology|October 6, 2009
A first step to assess harm and benefit in clinical trials in one scaleMaarten Boers, Peter Brooks, James F Fries, et al.
Journal of Pain Research|May 26, 2015
Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trialsVibeke Strand, Louis F McIntyre, William R Beach, et al.
Current Medical Research and Opinion|August 22, 2019
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world dataVibeke Strand, Ruchitbhai Shah, Chris Atzinger, et al.
Expert Opinion on Biological Therapy|April 20, 2022
Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritisVibeke Strand, Lixia Zhang, Alix Arnaud, et al.
Current Medical Research and Opinion|January 31, 2017
The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilarVibeke Strand, Giampiero Girolomoni, Martin Schiestl, et al.
The Lancet. Rheumatology|October 23, 2024
Explanation for substandard of care comparators in rheumatology randomised trial protocolsJacky Sheng, Andrew Zhang, Hannah Moyer, et al.
The Journal of Rheumatology|June 5, 2003
Leflunomide for the treatment of rheumatoid arthritis: a systematic review and metaanalysisManathip Osiri, Beverley Shea, Vivian Robinson, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 14, 2019
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.
The Lancet. Rheumatology|January 22, 2024
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysisLihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 28, 2020
Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.
Pageof 44

Showing results (111-120 of 435) with videos related to

Sort By:
Pageof 44
Journal of Clinical Epidemiology|October 6, 2009
A first step to assess harm and benefit in clinical trials in one scaleMaarten Boers, Peter Brooks, James F Fries, et al.
Journal of Pain Research|May 26, 2015
Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trialsVibeke Strand, Louis F McIntyre, William R Beach, et al.
Current Medical Research and Opinion|August 22, 2019
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world dataVibeke Strand, Ruchitbhai Shah, Chris Atzinger, et al.
Expert Opinion on Biological Therapy|April 20, 2022
Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritisVibeke Strand, Lixia Zhang, Alix Arnaud, et al.
Current Medical Research and Opinion|January 31, 2017
The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilarVibeke Strand, Giampiero Girolomoni, Martin Schiestl, et al.
The Lancet. Rheumatology|October 23, 2024
Explanation for substandard of care comparators in rheumatology randomised trial protocolsJacky Sheng, Andrew Zhang, Hannah Moyer, et al.
The Journal of Rheumatology|June 5, 2003
Leflunomide for the treatment of rheumatoid arthritis: a systematic review and metaanalysisManathip Osiri, Beverley Shea, Vivian Robinson, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 14, 2019
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.
The Lancet. Rheumatology|January 22, 2024
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysisLihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 28, 2020
Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory DocumentsVibeke Strand, Joao Gonçalves, Timothy P Hickling, et al.
Pageof 44